Thalassemia Diagnosis Center of Mediterranean Blood Diseases Foundation, Antalya (Turkey).
Red Blood Cell and Haematopoietic Disorders Unit, Institute for Leukemia Research Josep Carreras (IJC) and University of Barcelona, Catalonia (Spain).
Acta Biomed. 2021 Sep 2;92(4):e2021410. doi: 10.23750/abm.v92i4.11965.
Sickle cell disease (SCD) and thalassemias are the most common monogenic diseases in the world. The number of migrants and refugees in Europe and Turkey, in the past decade, has increased dramatically due to war, violence or prosecutions in their homeland. Prevention and management of haemoglobin disorders is well established and managed in countries where these conditions were traditionally endemic or in countries that have a longstanding tradition of receiving migrants. Therefore, preventive and diagnostic programmes regarding hemoglobinopathies in immigrant populations have been implemented. The purpose of this paper it to report a summary of the experience gained in Italy, Spain and Turkey in migrants, asylum seekers and refugees.
镰状细胞病（SCD）和地中海贫血症是世界上最常见的单基因疾病。由于战争、暴力或在原籍国受到起诉，过去十年来，欧洲和土耳其的移民和难民人数急剧增加。在这些疾病传统流行的国家或在长期接收移民的国家，血红蛋白疾病的预防和管理已经得到很好的确立和管理。因此，已经针对移民人群中的血红蛋白病实施了预防和诊断计划。本文的目的是报告意大利、西班牙和土耳其在移民、寻求庇护者和难民方面所获得经验的总结。
